Clinical Guidelines & Pathways


GLP-1 agonist Prescribing Guideline


This guideline is currently being updated to reflect the availability of certain products - In the meantime , please contact the Medicine Management Team if you need any advice / further clarification.

Guideline Categories: Endocrinology and Diabetes

Guideline Areas: Bedfordshire, Luton, Milton Keynes

Guideline Tags: dulaglutide, Glucagon-like peptide 1 (GLP 1) agonists, liraglutide, semaglutide, type 2 diabetes

Please use the search box to search the whole site if you can't find what you're looking for:

To top